Argent Trust Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.07M | Sell |
2,398
-506
| -17% | -$225K | 0.04% | 310 |
|
|
2025
Q1 | $1.41M | Sell |
2,904
-390
| -12% | -$189K | 0.06% | 265 |
|
|
2024
Q4 | $1.33M | Buy |
3,294
+1
| +0% | +$403 | 0.05% | 272 |
|
|
2024
Q3 | $1.53M | Buy |
3,293
+49
| +2% | +$22.8K | 0.06% | 252 |
|
|
2024
Q2 | $1.52M | Buy |
3,244
+19
| +0.6% | +$8.91K | 0.07% | 245 |
|
|
2024
Q1 | $1.35M | Buy |
3,225
+217
| +7% | +$90.7K | 0.06% | 262 |
|
|
2023
Q4 | $1.22M | Buy |
3,008
+431
| +17% | +$175K | 0.06% | 250 |
|
|
2023
Q3 | $896K | Buy |
2,577
+90
| +4% | +$31.3K | 0.05% | 285 |
|
|
2023
Q2 | $875K | Buy |
2,487
+228
| +10% | +$80.2K | 0.05% | 298 |
|
|
2023
Q1 | $712K | Hold |
2,259
| – | – | 0.05% | 306 |
|
|
2022
Q4 | $652K | Sell |
2,259
-112
| -5% | -$32.3K | 0.04% | 309 |
|
|
2022
Q3 | $686K | Sell |
2,371
-40
| -2% | -$11.6K | 0.05% | 283 |
|
|
2022
Q2 | $680K | Hold |
2,411
| – | – | 0.05% | 296 |
|
|
2022
Q1 | $629K | Sell |
2,411
-350
| -13% | -$91.3K | 0.04% | 320 |
|
|
2021
Q4 | $606K | Buy |
2,761
+454
| +20% | +$99.6K | 0.04% | 332 |
|
|
2021
Q3 | $418K | Sell |
2,307
-130
| -5% | -$23.6K | 0.03% | 378 |
|
|
2021
Q2 | $491K | Buy |
2,437
+511
| +27% | +$103K | 0.03% | 344 |
|
|
2021
Q1 | $413K | Sell |
1,926
-230
| -11% | -$49.3K | 0.03% | 363 |
|
|
2020
Q4 | $510K | Buy |
2,156
+237
| +12% | +$56.1K | 0.04% | 316 |
|
|
2020
Q3 | $522K | Sell |
1,919
-18
| -0.9% | -$4.9K | 0.05% | 288 |
|
|
2020
Q2 | $563K | Sell |
1,937
-291
| -13% | -$84.6K | 0.05% | 266 |
|
|
2020
Q1 | $530K | Sell |
2,228
-117
| -5% | -$27.8K | 0.06% | 253 |
|
|
2019
Q4 | $514K | Buy |
2,345
+202
| +9% | +$44.3K | 0.05% | 294 |
|
|
2019
Q3 | $362K | Buy |
2,143
+1,000
| +87% | +$169K | 0.03% | 342 |
|
|
2019
Q2 | $209K | Buy |
+1,143
| New | +$209K | 0.02% | 420 |
|